Both in Pharmaceuticals
MacroGenics vs Journey Medical
Over the past year MGNX returned +45.3% and DERM returned −43.7%; their daily moves had a correlation of 0.19.
MGNX +45.3% DERM −43.7%Growth of $1, one year, split-adjusted
| Metric | MGNX | DERM |
|---|---|---|
| Price | $2.30 | $4.80 |
| Market cap | $146.2M | $135.5M |
| Today | −1.50% | +3.45% |
| 1 month | −37.0% | −22.1% |
| 6 months | −23.8% | −7.9% |
| Year to date | +42.5% | −37.7% |
| 1 year | +45.3% | −43.7% |
| Revenue growth (YoY) | +378.0% | +18.9% |
| Gross margin | 100.0% | 65.6% |
| Net margin | 59.4% | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.9× | 2.0× |
| Net cash | $173.3M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | 64.8% |
| Short % of float | 8.2% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).